These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 23153327)

  • 1. Behcet's Syndrome.
    Dalvi SR; Yildirim R; Yazici Y
    Drugs; 2012 Dec; 72(17):2223-41. PubMed ID: 23153327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behçet's syndrome: a critical digest of the 2014-2015 literature.
    Hatemi G; Seyahi E; Fresko I; Talarico R; Hamuryudan V
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S3-14. PubMed ID: 26487500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update on the treatment of Behçet's syndrome.
    Esatoglu SN; Hatemi G
    Intern Emerg Med; 2019 Aug; 14(5):661-675. PubMed ID: 30684097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behçet's syndrome: facts and controversies.
    Mat C; Yurdakul S; Sevim A; Özyazgan Y; Tüzün Y
    Clin Dermatol; 2013; 31(4):352-361. PubMed ID: 23806152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of ultrasound biomicroscopy, indocyanine green angiography and HLA-B51 testing as adjunct methods in the appraisal of Behçet's uveitis.
    Klaeger AJ; Tran VT; Hiroz CA; Morisod L; Herbort CP
    Int Ophthalmol; 2004 Jan; 25(1):57-63. PubMed ID: 15085978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adamantiades-Behçet Disease at the Beginning of the Silk Route: North-East Italian Experience.
    Bergamo S; di Meo N; Stinco G; Bonin S; Trevisini S; Trevisan G
    Acta Dermatovenerol Croat; 2017 Dec; 25(4):295-297. PubMed ID: 30064603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet's disease in Taiwan.
    Hu YC; Yang YH; Lin YT; Wang LC; Yu HH; Lee JH; Chiang BL
    BMC Pediatr; 2019 Jul; 19(1):232. PubMed ID: 31296171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical profiling, treatment characteristics and outcome in Behcet's Disease (BD)-A retrospective cohort study from Karnataka Rheumatology Association (KRA).
    Rao VK; Kodali RS; Patil A; Chebbi P; Subramanian R; Kumar S; Singh YP; Chandrashekara S; Shobha V
    Clin Rheumatol; 2024 Oct; 43(10):3223-3230. PubMed ID: 39096360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Behcet's syndrome.
    Karadag O; Bolek EC
    Rheumatology (Oxford); 2020 May; 59(Suppl 3):iii108-iii117. PubMed ID: 32348509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Progress in interferon: A treatment of Behcet syndrome].
    Yan D; Zheng WJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1166-1170. PubMed ID: 33331331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of TNF-alpha antagonist and other immunomodulators in the treatment of patients with ophthalmologic manifestations of Behcet's disease and HLA B51 positive vasculitis].
    Zlatanović G; Jovanović S; Veselinović D; Zivković M
    Vojnosanit Pregl; 2012 Feb; 69(2):168-74. PubMed ID: 22500372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eye and Behçet's disease.
    Ksiaa I; Abroug N; Kechida M; Zina S; Jelliti B; Khochtali S; Attia S; Khairallah M
    J Fr Ophtalmol; 2019 Apr; 42(4):e133-e146. PubMed ID: 30850197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of Behçet's syndrome.
    Fresko I; Yurdakul S; Hamuryudan V; Ozyazgan Y; Mat C; Tanverdi MM; Yazici H
    Ann Med Interne (Paris); 1999 Nov; 150(7):576-81. PubMed ID: 10637674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behçet's disease.
    Bonfioli AA; Orefice F
    Semin Ophthalmol; 2005; 20(3):199-206. PubMed ID: 16282155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behçet's syndrome: providing integrated care.
    Esatoglu SN; Kutlubay Z; Ucar D; Hatemi I; Uygunoglu U; Siva A; Hatemi G
    J Multidiscip Healthc; 2017; 10():309-319. PubMed ID: 28860798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute psychosis and Behçet's disease: a case report].
    Nkam I; Cottereau MJ
    Encephale; 2006; 32(3 Pt 1):385-8. PubMed ID: 16840933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between the parenchymal neurological involvement and posterior uveitis in Behçet's syndrome.
    Bitik B; Tufan A; Sahin K; Sucullu Karadag Y; Can Sandikci S; Mercan R; Ak F; Karaaslan Y; Ozturk MA; Goker B; Haznedaroglu S
    Clin Exp Rheumatol; 2016; 34(6 Suppl 102):82-85. PubMed ID: 27791948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of Behcet's syndrome among men with mucocutaneous involvement at disease onset: long-term outcome of patients enrolled in a controlled trial.
    Hamuryudan V; Hatemi G; Tascilar K; Sut N; Ozyazgan Y; Seyahi E; Mat C; Yurdakul S; Yazici H
    Rheumatology (Oxford); 2010 Jan; 49(1):173-7. PubMed ID: 19995858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current therapy for Behçet's disease.
    Goker B; Goker H
    Am J Ther; 2002; 9(5):465-70. PubMed ID: 12237740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of vascular Behçet's disease.
    Alibaz-Oner F; Direskeneli H
    Int J Rheum Dis; 2019 Jan; 22 Suppl 1():105-108. PubMed ID: 29665281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.